Individuals Discontinuing Slimming Medications Regain Weight Four Times Faster Compared to Dieters

A recent study indicates that individuals who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who halt conventional lifestyle regimens.

Research printed in a leading health publication demonstrates that while obese individuals frequently drop about a fifth of their body weight while on the medication, the weight comes back at an average rate of nearly a kilo each month once they quit.

"Users buying these medications should be aware of the danger of quick weight regain when the therapy ends," warns expert Dr. Susan Jebb.

This pace of recovery suggests a reversion to original mass within about 18 months.

Comparing Therapies

The research, which reviewed dozens of trials involving thousands of participants, contrasted the effects of the injectable medications with older methods.

Scientists point out that people who lose weight through diet and exercise usually see a more gradual weight regain—around 0.1 kg a month—once they finish.

Explaining the Rapid Regain

Experts propose the mechanism of the drugs explains the amplified regain.

GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate appetite.

"Artificially providing GLP-1 levels far above than the body's typical production may cause the system to generate a reduced amount of its own natural GLP-1, and may also reduce responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert.

"Withdrawal of this hormone supplement leads to hunger is unsuppressed, making overeating a significant risk."

An Ongoing Issue?

Medical guidelines recommend the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.

Professionals contend that, considering the likelihood of weight regain, the treatment should be considered long-term.

This view is supported by pharmaceutical companies, who say that the findings "highlight the long-term character of obesity," akin to managing conditions like diabetes.

Patient Testimonies

Individuals who have discontinued the jabs explain a sudden resurgence of cravings.

"It felt as if a trigger that goes on and I was suddenly starving," described one woman.

This difficulty is worsened if users have not adopted sustainable lifestyle or habit changes during treatment.

Significant Use

Figures show that a significant number of people in the UK have tried these injections in the last 12 months, with demand being substantial.

• Use is greater among women than men.
• The 40s and 50s age group shows the greatest usage rates.
• Many obtain the drugs through private healthcare rather than public health services.

Finally, researchers emphasize that while the jabs are effective tools for shedding pounds, they are not a magic cure and long-term success relies on ongoing lifestyle management.